|
|
||||||||
Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
Correspondence
Annika Antonsson
a.antonsson{at}uq.edu.au
| ABSTRACT |
|---|
|
|
|---|
The GenBank/EMBL/DDBJ accession number for the partial L1 sequence of the putative new HPV type FADI1 is EU340869.
| INTRODUCTION |
|---|
|
|
|---|
Many studies have also suggested a role for HPV in the carcinogenesis of non-melanoma skin cancer (NMSC). Squamous cell carcinoma (SCC) can metastasize, and is known as the unfavourable form of NMSC compared with basal cell carcinoma (BCC). Interestingly, BCCs are found approximately three times more frequently in immunocompetent individuals; however, in immunosuppressed organ-transplant recipients, SCCs are more prevalent (Pfister, 2003
). It has been reported that more HPV types have been found in actinic keratosis and SCC skin lesions than in normal skin (Alotaibi et al., 2006
), and a greater variety of HPV types have also been found in immunosuppressed individuals than in immunocompetent individuals (Harwood et al., 2004
). Both SCC and BCC develop mostly on sun-exposed sites (Frost & Green, 1994
), and some specific types of HPV, including HPV-5, HPV-8, HPV-20 and HPV-77, have been shown to be activated by UV radiation (Akgül et al., 2005
; Massimi et al., 2008
; Michel et al., 2006
; Purdie et al., 1999
; Storey et al., 1998
). Evidence of UV-induced E6/E7 oncogenicity and transcriptional activity of E6/E7 oncogenes in NMSC has been found (Al Moustafa et al., 2004
; Dang et al., 2006
; Michel et al., 2006
). Furthermore, differences in transforming activity potential between various cutaneous HPV types have been shown, providing further evidence for a role of cutaneous HPV in the development of NMSC (Massimi et al., 2008
).
Recent reports have suggested that HPV DNA is more prevalent on sun-exposed sites in both normal skin and skin lesions (Antonsson et al., 2000
; Forslund et al., 2003
). Given the high rate of sun exposure in Australia, as evidenced by the country having the highest rates of skin cancer in the world, we undertook a population survey of skin HPV frequency in workers with or without a history of frequent sun exposure. This study has identified HPV-76 as a more frequently occurring HPV type in healthy individuals who were not frequently exposed to the sun.
| METHODS |
|---|
|
|
|---|
Questionnaire.
A two-page questionnaire was given to each of the participants. The first section of the questionnaire included questions about the participant's age, sex, ethnic background, skin type and eye and hair colour, to provide a brief personal background and to allow the matching of age and sex of individuals from the two study groups. The second section of the questionnaire involved a more detailed analysis of the participant's history of skin cancer and other skin conditions. History of cancer and organ transplantation was also surveyed to provide information about the immune status of the participants. Questions relating to the participant's family history of skin cancer were also included to give indications as to whether there could be hereditary issues associated with skin cancers. The third section of the questionnaire was a self-assessment of sun exposure. Participants were asked about the number of hours per day spent outdoors, degree of tan, strategies used to protect themselves from the sun, frequency of sunburns as a child and the number of sunburns occurring during the last 12 months.
Samples.
Samples were collected with pre-wetted (in 0.9 % NaCl solution) cotton-tipped swabs (Sarstedt) that were drawn back and forth five times over the forehead skin within an area of 5x10 cm. The swabs were suspended in 1 ml 0.9 % NaCl solution (Baxter) in a 1.5 ml Eppendorf tube, and analysed within 48 h of collection. All samples were left at room temperature for as little time as possible, and samples that were not analysed immediately were kept at 4 °C.
PCR.
PCR using the FAP primer pair is able to detect most cutaneous HPV types (Forslund et al., 1999
). The 25 µl PCR contained 5 µl neat sample, 0.75 µM of each primer (FAP59/FAP64) (Forslund et al., 1999
), 3.5 mM MgCl2, 0.2 mM of each dNTP (Fisher), 0.2 % BSA (Sigma), 0.625 U AmpliTaq Gold DNA polymerase (Applied Biosystems) and GeneAmp PCR buffer II (Applied Biosystems). The PCR was incubated for 10 min at 94 °C, followed by 45 amplification cycles of 94 °C for 90 s, 50 °C for 90 s and 72 °C for 90 s. Distilled water was used as a negative control; a patient sample containing HPV-18 was used as a positive control. A PCR using Human L1-F and Human L1-R primers (Deragon et al., 1990
) was carried out on all samples to ensure that they contained human DNA and that no PCR-inhibiting agents were present. All reactions were undertaken in a Thermo Hybaid PxE PCR machine. PCR products were analysed using agarose gel electrophoresis. Agarose gels (1.5 %) were made with 1x TAE buffer and stained with 10 mg ethidium bromide ml–1.
Cloning and sequencing.
FAP PCR products of HPV-positive samples were cloned into the pCR-script SK(+) cloning vector (Stratagene) or the pCR 2.1-TOPO cloning vector (Invitrogen). Plasmid DNA of bacterial colonies with inserts of HPV DNA was purified using a Wizard mini-prep purification kit (Promega). The plasmid DNA was sequenced with T7 or T3 primer for the Stratagene reactions and M13 Forward or M13 Reverse primer for the Invitrogen reaction. Sequencing reactions were performed using the CentriSep machine, ABI PN#401762. The GenBank BLAST search (http://www.ncbi.nlm.nih.gov/blast) (Altschul et al., 1997
) was used to compare sequences and to identify HPV types. One to three clones were analysed per HPV-positive sample.
Statistical analysis.
The
2 test was used to compare the prevalence of HPV DNA among SE and NSE individuals and to compare the distribution of HPV types detected. Fisher's exact test was used to identify frequently occurring HPV types, and to determine the prevalence of multiple HPV types. A P-value less than 0.05 was considered statistically significant in the
2 test and Fisher's exact test. Odds ratios and 95 % confidence intervals for the outcome variable HPV DNA positivity and a number of independent variables from the questionnaire were calculated using logistic regression. Variables with P<0.1 in univariate analysis were included in a multiple logistic regression analysis, and a P-value less than 0.05 in the multiple regression analysis was considered statistically significant.
Ethical approval.
This research has been approved by the University of Queensland Medical Research Ethics Committee under the approval number 2006000670.
| RESULTS |
|---|
|
|
|---|
|
HPV type determination and analysis
In order to determine the identity of each HPV type present in our samples, DNA sequence analysis was performed. Twenty-one of the 27 SE HPV DNA-positive samples and 21 of 24 NSE HPV-DNA-positive samples could be cloned and sequenced, and a wide diversity of HPV types was found (Fig. 1
). A total of 48 sequences were identified in the SE group, and 50 sequences were identified from the NSE group. We had aimed to sequence three clones from each HPV DNA-positive sample. However, of 51 HPV-DNA-positive samples, 25 samples yielded three HPV sequences, six samples had two HPV types sequenced, 11 samples had one HPV type sequenced and nine samples were not able to yield the sequence of any HPV type. Twenty-six HPV types were detected from the SE group, including one new HPV type. This new HPV type was 437 bp in length, and was 81 % similar to HPV FA53. Our new putative HPV type was named FADI1 (where FA stands for the primer pair used and DI for the institute, i.e. Diamantina Institute, Brisbane, Australia). Twenty HPV types were detected from the NSE group; no new HPV type was found.
|
A broad spectrum of types from both the β and
cutaneous HPV species was found in this study, but the differences in the distribution of each species were found not to be significant (
2 test, P=0.28). Analysis of the number of HPV types detected per sample revealed that individuals who were frequently sun-exposed were more likely to carry multiple types of HPV; however, the result was not statistically significant (Fisher's exact test, P=0.11). Furthermore, none of the samples contained more than two HPV types in either of the groups.
Analysis of HPV DNA prevalence in relation to variables from the questionnaire
According to the questionnaire, none of the participants had a history of organ transplantation, hence all participants were considered immunocompetent. In order to analyse the variants in relation to prevalence of HPV DNA, univariate analysis and multiple regression analysis were carried out. Referring to the statistical analysis, HPV DNA prevalence was not related to family history of skin cancer (P=0.76) or history of moles, warts or other skin conditions such as eczema and dermatitis (P=0.56, P=0.41 and P=0.39, respectively) (Table 2
). Individuals with various ethnic backgrounds, skin types, degree of tan, different number of recent sunburns and frequency of sunburns as children also had similar HPV DNA prevalence. Furthermore, use of an increased number of several common sun-protection methods did not show any relationship to HPV prevalence (P=0.59). These sun-protection methods included wearing a hat (P=0.52), wearing protective clothing (P=0.93) and using sunscreens (P=0.43).
|
|
| DISCUSSION |
|---|
|
|
|---|
Firstly, we noted no significant difference in overall HPV DNA prevalence between the SE group and the NSE group. One explanation for this may be the variation in sun protection practices between age groups in the SE group (e.g. we noted that younger participants tend to wear sunglasses and protective long-sleeved clothes more than older workers). Therefore, different levels of sun protection method may have confounded the results. A previous study found increasing HPV prevalence with older age (Antonsson et al., 2000
). However, statistical analysis in this study did not show a significant increase in HPV prevalence with increasing age using multiple regression analysis (P=0.25). Furthermore, our measure of sun exposure was based on reported self-assessment during the interview. However, given this, it was shown that there was a direct relationship between increased time spent outdoors and detection of HPV DNA (Tables 2
and 3
). These data indicate that the more years spent working outdoors and the longer the time spent outdoors, the greater the risk of increased cutaneous HPV in normal skin. The logical explanation for these findings is that UV radiation plays a role in cutaneous HPV prevalence in normal skin, and that the variable number of hours spent outdoors could be a better measure of sun exposure than the binary variables SE and NSE to determine any difference between these two groups.
Healthy individuals carry multiple HPV types (Antonsson et al., 2000
, 2003a
, b
; Hazard et al., 2006
); therefore, we analysed the presence of multiple HPV infections in both study groups. Our study shows that multiple HPV types were more common in individuals who are frequently exposed to the sun (P=0.073). One explanation for this could be immune suppression induced by increased exposure to UV radiation (Pamphilon et al., 1991
; Parrish et al., 1983
). However, a more thorough understanding of the cutaneous HPV transmission pathway and virus–host interactions would be needed in order to identify the mechanisms of HPV persistence in human skin.
Overall, a large spectrum of HPV types from both the β and
HPV groups was detected. Although there was no significant difference in HPV group distribution between the two study groups, a greater number of HPV types from the β2 and
group were detected within the SE group. A recent publication (Forslund et al., 2007
) suggested that cutaneous β2 HPV species predominate in sun-exposed skin in SCC. In our study, HPV-76, which belongs to the β3 group, was only detected within the NSE group. Future research could involve growing HPV-76 and HPV types from the β2 and
HPV group in raft culture (Bell et al., 1983
; Regnier et al., 1981
), so the mechanism of action of these HPV types in skin tissues can be investigated.
UV radiation damages DNA by inducing mutations and impairing apoptosis, leading to cancer formation (Ruhland & de Villiers, 2001
). It has also been found to have suppressing effects on the immune system through skin-mediated responses (Kripke, 1988
; Morison, 1989
; Noonan & De Fabo, 1992
). Increased presence of HPV DNA was detected in the forehead skin swabs of individuals with increased numbers of previous skin cancers, suggesting that increased numbers of previous skin cancers may be a risk factor for cutaneous HPV. It has been found that people who are often exposed to the sun with poor sun protection methods are more likely to develop both MSC and NMSC (Dummer & Maier, 2002
), with Caucasians who have fair skin types having a higher risk (Neugut et al., 1994
). Our result did not show a higher prevalence of HPV DNA in Caucasians and individuals with fair skin type, and most participants who had a history of skin cancer had NMSC. Cutaneous HPV DNA has been found to be more common on skin than in NMSC biopsies, suggesting that cutaneous HPV may be necessary for NMSC development, but not essential once the tumour has formed (hit-and-run) (Boxman et al., 2000
; Forslund et al., 2004
; Purdie et al., 1993
). However, the role of HPV in NMSC is still controversial.
Surprisingly, our results show that individuals who wore sunglasses had lower HPV DNA prevalence in forehead skin swabs, while other sun protection methods did not show any benefit in terms of lower HPV DNA prevalence. Suppression of immune functions can occur through an eye–brain-mediated response (Denis et al., 1993
; Jankovic, 1994
; Moore & Klein, 1974
; Roberts, 1995
), so one explanation for this result would be that sunglasses decrease the amount of UV light reaching the eyes and therefore the pineal gland. This would result in an upregulation of melatonin and thus reduce any immune suppression caused by UV radiation. The eye–brain mechanism is also age-dependent, due to variations in the filtering characteristics of the lens throughout life (Dillon, 1991
). A decrease in immune responsiveness with age has been suggested to be the result of a decrease in melatonin production (Caroleo et al., 1992
; Maestroni & Conti, 1991
; Maestroni, 1993
). These findings may also explain why increasing prevalence of HPV DNA was detected with increasing age in a previous study by Antonsson et al. (2000)
. Additional studies to elucidate the mechanism(s) of immune enhancement caused by the blockage of UV radiation detection from the eyes in relation to HPV prevalence should be carried out to determine whether sunglasses are protective against HPV.
This study investigated HPV prevalence and type spectrum in healthy males who are frequently sun-exposed in comparison to healthy males who are not frequently sun-exposed. Our results suggested that UV radiation plays a role in cutaneous HPV prevalence in normal skin, and an increased number of skin cancers may be a risk factor for cutaneous HPV. Furthermore, HPV-76 was only detected among the NSE group. Elucidation of the transmission mechanism of cutaneous HPV would result in greater understanding of this virus.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Al Moustafa, A. E., Foulkes, W. D., Benlimame, N., Wong, A., Yen, L., Bergeron, J., Batist, G., Alpert, L. & Alaoui-Jamali, M. A. (2004). E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 23, 350–358.[CrossRef][Medline]
Alotaibi, L., Provost, N., Gagnon, S., Franco, E. L. & Coutlee, F. (2006). Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. J Clin Virol 36, 133–140.[CrossRef][Medline]
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. & Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25, 3389–3402.
Antonsson, A., Forslund, O., Ekberg, H., Sterner, G. & Hansson, B. G. (2000). The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 74, 11636–11641.
Antonsson, A., Erfurt, C., Hazard, K., Holmgren, V., Simon, M., Kataoka, A., Hossain, S., Hakangard, C. & Hansson, B. G. (2003a). Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 84, 1881–1886.
Antonsson, A., Karanfilovska, S., Lindqvist, P. G. & Hansson, B. G. (2003b). General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 41, 2509–2514.
Astori, G., Lavergne, D., Benton, C., Hockmayr, B., Egawa, K., Garbe, C. & de Villiers, E.-M. (1998). Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 110, 752–755.[CrossRef][Medline]
Bell, E., Sher, S., Hull, B., Merrill, C., Rosen, S., Chamson, A., Asselineau, D., Dubertret, L., Coulomb, B. & other authors (1983). The reconstitution of living skin. J Invest Dermatol 81, 2s–10s.[CrossRef][Medline]
Boxman, I. L. A., Mulder, L. H. C., Vermeer, B. J., Bavinck, J. N. B., ter Schegget, J. & Ponec, M. (2000). HPV-DNA is not detectable in outgrowing cells from explant cultures of skin lesions established at the air–liquid-interface. J Med Virol 61, 281–288.[CrossRef][Medline]
Caroleo, M. C., Frasca, D., Nistica, G. & Doria, G. (1992). Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 23, 81–89.[CrossRef][Medline]
Dang, C., Koehler, A., Forschner, T., Sehr, P., Michael, K., Pawlita, M., Stockfleth, E. & Nindl, I. (2006). E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br J Dermatol 155, 129–136.[CrossRef][Medline]
Denis, P., Nordmann, J. P., Elena, P. P. & Dussaillant, M. (1993). Physiological roles of dopamine and neuropeptides in the retina. Fundam Clin Pharmacol 7, 293–304.[Medline]
Deragon, J.-M., Sinnett, D., Mitchell, G., Potier, M. & Labuda, D. (1990). Use of
irradiation to eliminate DNA contamination for PCR. Nucleic Acids Res 18, 6149
Dillon, J. (1991). New trends in photobiology: the photophysics and photobiology of the eye. J Photochem Photobiol B 10, 23–40.[CrossRef][Medline]
Dummer, R. & Maier, T. (2002). UV protection and skin cancer. Recent Results Cancer Res 160, 7–12.[Medline]
Forslund, O., Antonsson, A., Nordin, P., Stenquist, B. & Goran Hansson, B. (1999). A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 80, 2437–2443.
Forslund, O., Ly, H., Reid, C. & Higgins, G. (2003). A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 149, 64–73.[CrossRef][Medline]
Forslund, O., Lindelof, B., Hradil, E., Nordin, P., Stenquist, B., Kirnbauer, R., Slupetzky, K. & Dillner, J. (2004). High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "stripped" biopsies from the same tumors. J Invest Dermatol 123, 388–394.[CrossRef][Medline]
Forslund, O., Iftner, T., Andersson, K., Lindelöf, B., Hradil, E., Nordin, P., Stenquist, B., Kirnbauer, R., Dillner, J. & de Villiers, E.-M. (2007). Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 196, 876–883.[CrossRef][Medline]
Frost, C. A. & Green, A. C. (1994). Epidemiology of solar keratoses. Br J Dermatol 131, 455–464.[Medline]
Harwood, C. A., Surentheran, T., Sasieni, P., Proby, C. M., Bordea, C., Leigh, I. M., Wojnarowska, F., Breuer, J. & McGregor, J. M. (2004). Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150, 949–957.[CrossRef][Medline]
Hazard, K., Karlsson, A., Andersson, K., Ekberg, H., Dillner, J. & Forslund, O. (2006). Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 127, 116–119.[CrossRef][Medline]
Jankovic, B. D. (1994). Neuroimmunomodulation from phenomenology to molecular evidence. Ann N Y Acad Sci 741, 1–38.[Medline]
Kripke, M. L. (1988). Immunoregulation of carcinogenesis: past, present, and future. J Natl Cancer Inst 80, 722–727.
Maestroni, G. J. M. (1993). The immunoneuroendocrine role of melatonin. J Pineal Res 14, 1–10.[Medline]
Maestroni, G. J. & Conti, A. (1991). Anti-stress role of the melatonin-immuno-opioid network: evidence for a physiological mechanism involving T cell derived, immunoreactive β-endorphin and MET-enkephalin binding to thymic opioid receptors. Int J Neurosci 61, 289–298.[Medline]
Massimi, P., Thomas, M., Bouvard, V., Ruberto, I., Campo, M. S., Tommasino, M. & Banks, L. (2008). Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology 371, 374–379.[CrossRef][Medline]
Michel, A., Kopp-Schneider, A., Zentgraf, H., Gruber, A. D. & de Villiers, E.-M. (2006). E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 80, 11153–11164.
Moore, R. Y. & Klein, D. C. (1974). Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity. Brain Res 71, 17–33.[CrossRef][Medline]
Morison, W. L. (1989). Effects of ultraviolet radiation on the immune system in humans. Photochem Photobiol 50, 515–524.[Medline]
Neugut, A. I., Kizelnik-Freilich, S. & Ackerman, C. (1994). Black–white differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health 84, 1828–1829.
Noonan, F. P. & De Fabo, E. C. (1992). Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol Today 13, 250–254.[CrossRef][Medline]
Pamphilon, D. H., Alnaqdy, A. A. & Wallington, T. B. (1991). Immunomodulation by ultraviolet light: clinical studies and biological effects. Immunol Today 12, 119–123.[CrossRef][Medline]
Parrish, J. A., Kripke, M. L. & Morrison, W. L. (1983). Photoimmunology. New York: Plenum.
Pfister, H. (2003). Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31, 52–56.
Purdie, K. J., Sexton, C. J., Proby, C. M., Glover, M. T., Williams, A. T., Stables, J. N. & Leigh, I. M. (1993). Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus? Cancer Res 53, 5328–5333.
Purdie, K. J., Pennington, J., Proby, C. M., Khalaf, S., de Villiers, E.-M., Leigh, I. M. & Storey, A. (1999). The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 18, 5359–5369.[CrossRef][Medline]
Regnier, M., Prunieras, M. & Woodley, D. (1981). Growth of adult human epithelial cells on dermal substrate. In Epidermal Keratinocyte Differentiation and Fibrillogenesis (Frontiers in Matrix Biology vol. 9), pp. 4–35. Edited by M. Prunieras. Basel: S. Karger.
Roberts, J. E. (1995). Visible light induced changes in the immune response through an eye–brain mechanism (photoneuroimmunology). J Photochem Photobiol B 29, 3–15.[CrossRef][Medline]
Ruhland, A. & de Villiers, E.-M. (2001). Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokines. Int J Cancer 91, 828–834.[CrossRef][Medline]
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G. & Banks, L. (1998). Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer. Nature 393, 229–234.[CrossRef][Medline]
Received 28 April 2008;
accepted 18 July 2008.
This article has been cited by other articles:
![]() |
E.-M. de Villiers and K. Gunst Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesions J. Gen. Virol., August 1, 2009; 90(8): 1999 - 2004. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |